US equities |
MU $1,035.84 ▼-4.79% NVDA $230.48 ▼-2.94% SNDK $1,609.46 ▼-4.90% AMD $620.68 ▼-3.90% INTC $107.08 ▼-5.34% AAPL $340.42 ▲+1.11% META $720.89 ▼-0.06% SPCX $160.57 ▼-4.19%
FinancialContent

Articles published by Metagenomi, Inc.

News headline image
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi to Present at Jefferies Global Healthcare Conference in London
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Appoints Laurence Reid, PhD to its Board of Directors
From Metagenomi, Inc.
Via GlobeNewswire
Tickers KALV MGX
News headline image
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi to Present at Upcoming Scientific Meetings
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Reports Business Updates and Full Year 2024 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Announces New Appointment to its Board of Directors
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Presents Compact SMART Editing Platform at AIChE 7th International Conference on CRISPR Technologies
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi to Participate in Upcoming Investor Conferences
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
News headline image
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX